# Single Ascending Dose Challenge Study to Determine Safety and Reactogenicity of an Influenza Challenge Virus

> **NCT04106817** · PHASE1 · COMPLETED · sponsor: **WCCT Global** · enrollment: 35 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Live, wild-type A/California/H1N1 2009 influenza virus

## Key facts

- **NCT ID:** NCT04106817
- **Lead sponsor:** WCCT Global
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-19
- **Primary completion:** 2015-08-10
- **Final completion:** 2015-08-10
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2020-01-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04106817

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04106817, "Single Ascending Dose Challenge Study to Determine Safety and Reactogenicity of an Influenza Challenge Virus". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04106817. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*